ArticleFrontiers in psychiatry2025
Psychiatric outcomes after primary and secondary earthquake exposure: effects of loss, media, and treatment.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Earthquakes can cause substantial psychiatric morbidity including Post-Traumatic Stress Disorder (PTSD). While direct exposure effects are well known less is understood about relapse after indirect exposure. Following the 2023 Kahramanmaraş earthquakes clinicians observed renewed distress among survivors of the 2020 Aegean Sea earthquake. Understanding how media exposure individual factors contribute to symptom reactivation is important for post-disaster care. This study investigated factors linked to PTSD symptom relapse after repeated disaster exposure. Method: This prospective quantitative study (February 2023-February 2024) recruited patients from a psychiatry outpatient clinic following the Kahramanmaraş earthquakes. Individuals with earthquake-related complaints who had also experienced the 2020 Aegean Sea earthquake were enrolled. Post-traumatic stress symptoms were assessed using the Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) at baseline and at 1, 3, 6, 9, and 12 months. Resilience was measured using the Resilience Scale for Adults (RSA) at baseline. Sociodemographic and clinical variables, including prior psychiatric treatment and media exposure type, were recorded. Multivariate analysis of variance was used to examine longitudinal symptom trajectories and predictors. Results: The study included 87 participants (mean age = 48.8 ± 12.5yrs), the majority were female (85%). Following the Aegean Sea earthquake, 45% of participants received psychiatric treatment, with loss experience being the only significant predictor of treatment seeking (χ² = 14.90, p <.001). After the Kahramanmaraş earthquakes, 74.7% received psychiatric treatment. A significant effect of time on PCL-5 symptom severity across the 12-month follow-up (Pillais Trace = .40, F = 7.32, p <.001). Age and resilience were independently associated with PTSD severity, with resilience showing the strongest effect (F = 40.24, p <.001). Higher PCL-5 scores among those primarily exposed to traditional media (F = 5.11, p = .027), symptom trajectories did not differ over time. Conclusion: This study shows that indirect exposure to large-scale disasters can shape symptom trajectories in previously affected individuals. Resilience served as a protective factor, while prior treatment indicated both vulnerability and adaptive potential. Media exposure type also influenced symptom severity. These results highlight the value of assessing resilience, treatment history, and media use in trauma-informed care after repeated disaster exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.